Lifecore Biomedical, Inc., an integrated CDMO, has signed an agreement with a leading global pharmaceutical company. Under the agreement, Lifecore will transfer the commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities. Upon completion of the transfer and satisfaction of all regulatory requirements, Lifecore will be the commercial supplier of choice for the product.  This is the second agreement that Lifecore has signed...